Rosenberg S M, Gerhard H, Grunstein M M, Schramm C M
Division of Pulmonary Medicine, Children's Hospital of Philadelphia.
Chest. 1991 Sep;100(3):849-50. doi: 10.1378/chest.100.3.849.
The antimicrobial agent troleandomycin (TAO) has been shown to be effective in reducing corticosteroid requirements in patients with corticosteroid-dependent asthma. To our knowledge, the efficacy of TAO without concomitant use of corticosteroids has never been documented. We report the case of a 12-year-old patient with corticosteroid-dependent asthma who has remained asymptomatic and without any evidence of pulmonary deterioration during treatment with TAO without concomitant use of corticosteroids.
抗菌药物曲古霉素（TAO）已被证明在减少依赖皮质类固醇激素的哮喘患者对皮质类固醇激素的需求方面有效。据我们所知，从未有文献记载TAO在不联合使用皮质类固醇激素时的疗效。我们报告了一例12岁依赖皮质类固醇激素的哮喘患者，该患者在使用TAO且未联合使用皮质类固醇激素治疗期间一直无症状，且无任何肺部恶化的迹象。
